Soquelitinib Atopic Dermatitis Phase 1 Clinical Trial Data From Cohorts 1-3 anticipated to be Presented in MayInitial Results From First Two ...

A new review was published in , Volume 16, on March 13, 2025, titled "Signaling pathway dysregulation in breast cancer." ...

Oregon State University scientists have developed a highly efficient, uniquely shaped magnetic nanoparticle that could enable ...

Liver cancer, predominantly hepatocellular carcinoma (HCC), remains one of the most aggressive and leading causes of ...

Genelux Corporation’s GNLX share price has dipped by 12.21%, which has investors questioning if this is right time to buy.

Burning Rock Biotech Limited’s BNR share price has dipped by 12.36%, which has investors questioning if this is right time to ...

Odontogenic myxoma (OM) is a rare benign tumor originating from the odontogenic mesenchyme, characterized by locally aggressive behavior in the jaw bones. We present a case report of a 36-year-old ...

New, improved formulation set to replace EGRIFTA SV®MONTREAL, March 25, 2025 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (“Theratechnologies” or ...

Burning Rock Biotech Limited (NASDAQ: BNR, the "Company" or "Burning Rock"), a company focused on the application of next generation sequencing (NGS) ...

An update from CStone Pharmaceuticals ( ($HK:2616) ) is now available. CStone Pharmaceuticals announced its participation in the AACR 2025 Annual ...

Cesarean section, a surgical procedure for delivering a baby through an incision made in the mother’s abdomen, is generally ...